Skip to main content
Top

Breast Cancer Research and Treatment

Issue 2/2004

Content (11 Articles)

Calcitonin Receptor Gene and Breast Cancer: Quantitative Analysis with Laser Capture Microdissection

Xiaojuan Wang, Misa Nakamura, Ichiro Mori, Koichi Takeda, Yasushi Nakamura, Hirotoshi Utsunomiya, Goro Yoshimura, Takeo Sakurai, Kennichi Kakudo

Malignant Pleural and Pericardial Effusion in Invasive Breast Cancer: Impact of the Site of the Primary Tumor

W. Pokieser, P. Cassik, G. Fischer, M. Vesely, W. Ulrich, C. Peters-Engl

Loss of Heterozygosity on Chromosome 13q: Suggestion of a Candidate Tumor Suppressor Gene in Sporadic Breast Cancer

Dan Tong, Eva Schuster, Klaus Czerwenka, Sepp Leodolter, Robert Zeillinger

Fatigue, Weight Gain, Lethargy and Amenorrhea in Breast Cancer Patients on Chemotherapy: Is Subclinical Hypothyroidism the Culprit?

Nagi Kumar, Kathryn A. Allen, Diane Riccardi, Barry B. Bercu, Alan Cantor, Sue Minton, Lodovico Balducci, Paul B. Jacobsen

Motility Response to Insulin-like Growth Factor-I (IGF-I) in MCF-7 Cells is Associated with IRS-2 Activation and Integrin Expression

Xihong Zhang, Sailaja Kamaraju, Fumihiko Hakuno, Tomohiro Kabuta, Shin-Ichiro Takahashi, Deepali Sachdev, Douglas Yee

Instructions for Authors

Instructions for Authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine